Based on the fact that ITF2357 could enhance the efficacy of Pem to mut-KARS and wt-KARS NSCLC cells, we further studied whether ITF2357 reduced the resistance of mut-KRAS NSCLC cells to Pem. Here, KRAS is linked to non-small cell lung carcinoma.